Affymetrix Medical Genomics Research Program

Your partner in translating genomics discoveries into clinical tools

With a wide range of solutions and a proven path to market, Affymetrix enables clinical and medical researchers to confidently discover and validate genomic biomarkers.

Learn how published scientists have advanced their medical genomics research with Affymetrix technology by downloading their presentations below.

  • Learn more about Affymetrix solutions for medical genomics research

Presentations from the Medical Genomics Research Conference Series

View presentations from the European conference series

The Coriell Personalized Medicine Collaborative: Examining the Utility of Genome-informed Medicine

Michael Christman, President and CEO, Coriell Institute for Medical Research

Applications: Personalized
medicine, pharmacogenomics, genotyping

Developing a Global Frequency Distribution Database for Clinically Important Genetic Variations

Howard McLeod, Director, Institute for Pharmacogenomics and Individualized Therapy, University of North Carolina

Applications: Pharmacogenomics, genotyping

Pharmacogenomic Analysis of Adverse Drug Events and Interactions

Hakon Hakonarson,
Director, Center for Applied Genomics, Children's Hospital of
Philadelphia

Applications: Pharmacogenomics, genotyping

Expanding the Diagnostic Potential in Clinical Cytogenetics using SNP Oligonucleotide Microarray Analysis (SOMA)

Brynn Levy, Director of Clinical Cytogenetics, Columbia University

Applications: Constitutional cytogenetics, copy number, LOH, UPD

Challenges in Microarray-based Translational Molecular Diagnostics

Michael Datto, Assistant Professor, Duke University Medical Center

Applications: Whole-genome gene expression, biomarker discovery and validation

SNP Array Karyotyping for Clinical Cancer Applications

Jill Hagenkord, Director, Molecular Pathology and Clinical Genomics, Creighton Medical Labs

Applications: Cancer cytogenetics, copy number

Pathwork® Tissue of Origin Test: Identify Tumors with Uncertain Origins using FFPE Specimens

Raji Pillai, Director, Clinical Programs, Pathwork Diagnostics

Application: Whole-genome gene expression